about
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-bas...
Read More
4.04
-0.01
(-0.25%)
1.6M
XNAS Volume
XNAS 13 Jan, 2026 1:27 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
Altimmune Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..